Zoekresultaten - 8 results

papillomavirus (HPV) vaccine (Cervarix, GSK, Rixensart, Belgium) (1). The study completes and strengthens the evidence of the high level of effectiveness of primary cervical cancer prevention by HPV vaccination ...

should, by 2030, reach at least 90% HPV vaccine coverage among girls by the age of 15 years and also boys, if cost‐effective; they should introduce organised population‐based HPV ‐based screening and ...

estimates for 2018, approximately 33 000 cases of cervical cancer occurred and 15 000 people died from the disease in Europe (see map in appendix). Human papillomavirus (HPV) vaccine coverage is relatively ...

Papillomavirus Vaccines Uterine Cervical Neoplasms Vaccination Young adult Abstract: BACKGROUND: Early effects of HPV (human papillomavirus) vaccination are reflected by changes observable in young women attending ...

Publication Type: Peer reviewed scientific article Authors: Bray, Freddie; Lortet-Tieulent, Joannie; Znaor, Ariana; Brotons, Maria; Poljak, Mario; M. Arbyn Source: Vaccine, Volume 31 Suppl 7, ...

Issue 9, p.1969-82 (2012) Keywords: Anus Neoplasms Early Detection of Cancer Female Head and Neck Neoplasms Humans Male Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Penile Neoplasms ...

antibodies against the vaccine HPV types). We will assess clinical effectiveness by evaluating outcomes in all women, irrespective of the HPV DNA or serology status at enrolment. Evaluation by fine age and ...

genotyping of cervical cell samples and linkage with vaccine registries, are an important resource to address pending questions of the effect of HPV vaccination. Research is warranted to disentangle the causal ...